CTIS2022-502962-26-00RecruitingPhase 1
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE INFECTIONS (The MODIFY trial) - MODIFY
Hellenic Institute For The Study Of Sepsis0 sites190 target enrollmentStarted: February 10, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Enrollment
- 190
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 65+ (—)
- Sex
- All
Inclusion Criteria
- •Male or female, For women of child-bearing potential, willingness to avoid pregnancy during the study and agreement to notify investigator if pregnancy occurs., Age more than or equal to 18 years, Sepsis defined by the Sepsis-3 definition; this is defined separately for community-acquired sepsis and for hospital-acquired sepsis. Community-acquired sepsis is defined as any SOFA score 2 points or more for patients admitted in hospital emergencies with community-acquired pneumonia (CAP), community-acquired acute pyelonephritis (AP) or community-acquired primary bacteremia (BSI). CAP, AP and BSI are considered community-acquired for patients who have no history of hospitalization lasting more than 2 days the last 90 days or who are not under hemodialysis or who are not residents of long-term care facilities. Hospital-acquired sepsis is defined as any SOFA score increase by 2 points or more from the admission SOFA score for patients with onset of hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), acute pyelonephritis (AP) or primary bacteremia (BSI) at least 48 hours after hospital admission. For patients with history of hospitalization lasting more than 2 days the last 90 days or who are under hemodialysis or who are residents of long-term care facilities and are admitted to hospital with HAP, VAP, AP and BSI the definition of hospital-acquired sepsis applies. In this case, the baseline SOFA score is considered as the known SOFA score before infection onset., Presence of one of the following infections: community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), acute pyelonephritis (AP) and primary bacteremia (BSI)., Positive blood culture, Written informed consent provided by the patient or by their legal representative in case of patients unable to consent due to sepsis onset affecting their mental capacity., Patients who have completed their participation in another study for more than 30 days can be included in this study.
Exclusion Criteria
- •Failure to obtain written consent to participate, Previous enrollment in this study within the past 90 days. Patients enrolled in another study will not be accepted., Patients in pregnancy or breastfeeding. Women of child-bearing potential will be screened by a urine pregnancy test before inclusion in the study, Patients receiving prolonged antibiotic therapies (e.g. endocarditis, implantable device-associated infection, cerebral/hepatic abscess, osteomyelitis, meningitis), Patients with severe infections due to viruses or parasites (e.g. Dengue, Toxoplasma gondii, Plasmodium spp.), Patients with infection due to Mycobacterium tuberculosis, Patients suffering from cystic fibrosis, Severely immunocompromised patients such as a) patients with infection by the human immunodeficiency virus and with a CD4 count of less than 200 cells/mm3; b) neutropenic patients with less than 500 neutrophils/mm3; and c) patients with solid organ transplantation.
Investigators
Similar Trials
Active, not recruiting
Phase 1
A CLINICAL TRIAL FOR THE USE OF PROCALCITONIN IN EARLY STOP OF ANTIBIOTICS TO AVOID LONG-TERM CONSEQUENCESSE OF PROCALCITONIN IN EARLY STOP OF ANTIBIOTICS TO AVOID LONG-TERM CONSEQUENCESMedDRA version: 20.0 Level: PT Classification code 10040047 Term: Sepsis System Organ Class: 10021881 - Infections and infestationsEUCTR2017-002011-33-GRHellenic Institute for the Study of Sepsis280
Not yet recruiting
Phase 2
A randomized controlled clinical trial to evaluate the efficacy of Ajamoda Arka in Udarshool in Ksheerapavastha.CTRI/2023/07/055763Dr Surabhi Arun Yadgire
Not yet recruiting
Not Applicable
Study to compare the effect of two varieties of sudation treatment i.e. poultice sudation (Upanaha) and herbal bolus sudation (Choorna Pinda Sweda) with Kolakulatthadi Powder (Choorna) in the management of Low Back Pain (Katigraha)CTRI/2020/12/029605Parul Ayurved Hospital
Not yet recruiting
Unknown
To evaluate the effect of two different procedures Modified Shringa application(cupping therapy) and Jalauka avacharana(leech therapy) in the pain management of osteo arthritis of knee(janu sandhi gata vata)CTRI/2024/08/072473Dr Diwas Kumar Sethi
Not yet recruiting
Not Applicable
Effect of an ayurvedic drug on a viral infection that attack immune systemCTRI/2022/07/043626Patanjali Ayurvedic College